Earlier this summer, Monsanto twice offered to buy Syngenta for $45 million. Why would the US based chemical giant want to buy out its arch rival in Switzerland? The answer…
Carey Danis LoweAugust 17, 2015
OUR MOST RECENT POSTS
BLOG & NEWS CATEGORIES
- 401 K Litigation
- Actos
- ATV Accidents
- Auto Accidents
- bad faith
- Brain Injuries
- Burn Injuries
- Bus Accidents
- Class Action
- Commercial Litigation
- Consumer protection
- Dangerous Drugs
- Defective Medical Device litigation
- Depakote
- Drug Safety
- Fda Categories in St. Louis
- GMO
- Highway Safety
- Hip/Knee Replacement
- Invokana
- IVC Filters
- Jury Verdicts
- Laws
- Levaquin
- Lexapro
- Lost Wages
- Medical Malpractice
- Mirena
- Missouri Legal Decisions
- Missouri Verdicts and Settlements
- Monsanto
- Negligence
- NuvaRing
- Paxil
- Personal Injury
- Pharmaceutical litigation
- Pradaxa
- Predatory Lending
- Premises Liability
- Product Liability
- Prozac
- Recalls
- Reglan
- Risperdal
- Settlements
- St. Louis Mass Torts
- Testosterone
- Texting & Driving
- Topamax
- Traffic Safety
- Transvaginal Mesh
- Trucking Accidents
- Trucking Laws
- Trucking Regulations
- Uncategorized
- Unfair Deceptive Trades
- Verdicts and Settlements
- Wellbutrin
- Wrongful Death
- Yaz/Yasmin
- Zofran
- Zoloft
Tags
Actos
American Medical Systems
Bayer
birth control
birth defects
bladder cancer
blood clots
Boston Scientific
Boston Scientific Corp
C.R. Bard
Carey
Carey Danis
Carey Danis Lowe
class action
contraceptive
Danis
Danis Lowe
defective
DePuy
District Court
Drug Administration
Ethicon
Ethicon Gynecare Prolift
FDA
heart attack
Johnson Johnson
Judge Goodwin
lawsuit
litigation
Lowe
MDL
metal on metal
New Jersey
POP
Press Release
recall
side effects
SSRI
St. Louis
surgery
transvaginal mesh
United States
West Virginia
Yasmin
Yaz